|
News
-
11.30.2022Perkins Coie Announces 2023 Counsel PromotionsPress ReleasesPerkins Coie is pleased to announce that 53 attorneys have been promoted to the firm’s counsel position, effective January 1, 2023.
-
02.02.2022Perkins Coie’s Cannabis Law Industry Group Advises PepsiCo on New Hemp Energy Drink LaunchPress ReleasesPerkins Coie is pleased to announce that its Cannabis Law Industry Group advised PepsiCo regarding legal compliance for its hemp seed ingredient for the global food, snack, and beverage company’s new energy drink Rockstar Unplugged.
-
02.05.2021Perkins Coie’s Barak Cohen and Michael Bleicher Edit ABA’s First Cannabis Law Treatise at Pivotal Growth Moment for IndustryPress ReleasesPerkins Coie is pleased to announce that Barak Cohen, the firmwide chair of Perkins Coie’s Cannabis Law industry group, and Associate Michael Bleicher have edited the first American Bar Association treatise on cannabis law.
-
09.15.2020Perkins Coie Launches New Cannabis Industry BlogPress ReleasesPerkins Coie has launched a new blog covering the cannabis industry, including marijuana, CBD, and hemp-related businesses, that will provide timely updates and insights on the latest regulations, as well as evolving litigation, technology, and transaction trends impacting the sector.
-
03.12.2020Law.com Cites Barak Cohen and Michael Bleicher’s CBD Update on FDA report to CongressGeneral News
Law.com
Barak Cohen and Michael Bleicher’s CBD update on a FDA report to Congress was cited by Law.com, in the article "FDA Seeks More CBD Data," with respect to the agency’s ongoing enforcement approach to regulating the growing market for CBD products.
-
12.23.2019Perkins Coie Quoted in Food Processing - FDA Letters, Lawsuits Meet the First Generation of CBD ProductsGeneral NewsPerkins Coie was quoted in the Food Processing article, "FDA Letters, Lawsuits Meet the First Generation of CBD Products," regarding the FDA warning letters that were issued to companies selling products containing CBD at the end of November, which explicitly stated that the FDA has not proclaimed CBD as safe yet.
